leisure time -WSS

leisure time

author：comprehensive 2025-10-01 00:06:46 - browse：7

Adam's take main illustration — Molly Ferguson/STAT

MoonLake Immunotherapeutics, a Swiss biotech, was buried Monday under an avalanche of its own data spin.

It’s been awhile since I encountered a management team that speaks so arrogantly about the supposed supremacy of its own drug, but then fails to back up the talk with real data. MoonLake claimed its experimental antibody called sonelokimab delivered “landmark” results in a mid-stage study of psoriatic arthritis.

Landmark? That’s a strange way of describing the results of a clinical trial that showed sonelokimab topping a placebo — an easy hurdle — but failing to separate from an active treatment comparator, the generic drug adalimumab (known better as Humira).

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medicare proposal to cover medical devices draws a mixed reaction
Next article： Cheap, fast test for Zika and dengue could cost just $1

Wikipedia

WSS

Public health communication lessons from Covid

Cancer thrives by mutating. But sometimes, a mutation leaves it vulnerable

Lilly's Alzheimer's drug donanemab backed by FDA advisers

Study: Why relieving medical debt did not improve financial outcomes

Trump lawyers meet with special counsel in Jan. 6 case as potential indictment looms

Lilly's Alzheimer's drug donanemab backed by FDA advisers

entertainment

leisure time

hotspot

Trump demands the U.S. pay no more for drugs than other countries … again

Behind warning on Apellis’s eye drug lies a conflict of interest

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Stoke drug shows lower activity against childhood epilepsy

After affirmative action ruling, medical educators look to 'holistic review'

Moderna says combo Covid

United colonoscopy coverage change 'may cost lives,' doctors say

Trader Joe's recalls 10K cases of broccoli cheddar soup over potential foreign material

Medical records are filled with copy

California wildfire smoke linked to 52,000 early deaths, study says

focus

Teladoc has a new CEO, but challenges remain the same

The mammogram wars are not over

Bryan Kohberger seeks indictment dismissal in Idaho college killings case

Bryan Kohberger seeks indictment dismissal in Idaho college killings case

Lilly's Alzheimer's drug donanemab backed by FDA advisers

An outrageous hospital charge: I paid $710 for an hour of babysitting

leisure time

knowledge

Wikipedia

focus